glp-1 and seizures Could Drugs Lower Epilepsy Risk in People with Diabetes? GLP-1 medication and seizure risk?

All of this combines into a set of very good reasons why the FDA doesn't approve its use outside of specific conditions that are related to hGH deficiency in the first place

Unlike the injection, which can be given at any time, the pill requires a strict fasting window

[DOI] [PMC free article] [PubMed] [Google Scholar] 56

However, in addition to the therapeutic effects of GLP-1RA in patients with COVID-19, it is also important to evaluate the effectiveness of GLP-1RA in controlling comorbidities and risk factors influencing the development of chronic inflammation in vulnerable individuals

The strategy was then applied to semaglutide, a FDA approved GLP-1 analogue, to generate hybrid 24 and we showed that not only the in vivo activity was preserved, but the stability toward pancreatin was improved opening the way for improvement in oral administration